Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest autoimmune diseases Stories

2013-12-13 23:28:38

Sarcoidosis Remission Aden Protocol designed by Danielle May is the latest book that teaches people how to get rid of conditions such as dry eyes, arthritis, and skin lesions. Maya Kerensky from the site HealthReviewCenter.com performed a detailed Sarcoidosis Remission Aden Protocol review that indicates if this book is worth buying. Seattle, Wa (PRWEB) December 13, 2013 Sarcoidosis or Besnier-Boeck-Schaumann disease is a syndrome involving abnormal collections of chronic inflammatory...

2013-12-12 08:31:40

CHESTERBROOK, Pennsylvania, December 12, 2013 /PRNewswire/ -- Patients with ulcerative colitis (UC) can find information, tips and tools to help manage their disease at http://www.ShireUCentral.com Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, is pleased to announce the launch of http://www.ShireUCentral.com, an online disease information and resource center for US patients with ulcerative colitis...

2013-12-11 13:08:56

An experimental compound synthesized and developed by scientists from the Florida campus of The Scripps Research Institute (TSRI) has the capacity to significantly reduce joint inflammation in animal models of rheumatoid arthritis, an autoimmune disease that affects more than two million Americans. The study was published recently online ahead of print by the journal Arthritis & Rheumatism. The study showed the compound, known as SR2211, blocked development of virtually all symptoms...

2013-12-10 12:26:23

While Improved Efficacy Will Determine Uptake, Cost-Related Issues Will Drive Favorable Formulary Inclusion of Emerging Agents, According to a New Report from Decision Resources BURLINGTON, Mass., Dec. 10, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that lack of initial response or waning efficacy over time are the main reasons that patients discontinue treatment with leading...

2013-12-10 12:26:22

Drug Marketers Expected to Face Increasing Payer Restrictions, According to a New Report from Decision Resources BURLINGTON, Mass., Dec. 10, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the high cost per patient per year of biologics and novel oral therapies for the treatment of rheumatoid arthritis (RA) and psoriasis often results in reimbursement hurdles that limit patients'...

2013-12-10 08:31:37

Director of the Center for Neurogastroenterology at The Johns Hopkins University School of Medicine is the latest expert to participate in a free webinar series for scleroderma patients and caregivers. SAN FRANCISCO, Dec. 10, 2013 /PRNewswire-USNewswire/ -- Dr. Pankaj "Jay" Pasricha, Director of the Center for Neurogastroenterology and Professor of Medicine at The Johns Hopkins University School of Medicine will host a patient-focused webinar on Thursday, December 12, 2013 at 10...

2013-12-10 08:30:11

LOS ANGELES and NEW YORK, Dec. 10, 2013 /PRNewswire-USNewswire/ -- The Broad Medical Research Program, which funds innovative early-stage research into inflammatory bowel disease, will merge with the Crohn's & Colitis Foundation of America (CCFA), the two organizations announced today. (Logo: http://photos.prnewswire.com/prnh/20131210/DC30385LOGO-a) (Logo: http://photos.prnewswire.com/prnh/20131210/DC30385LOGO-b) The Broad Medical Research Program was started by The Eli and...

2013-12-09 23:02:16

IT GUTS BETTER, will officially kick-off on Tuesday, December 10, 2013. The project was created and founded by Metro Maryland Ostomy Association President, Scott Bowling. Rockville, MD (PRWEB) December 09, 2013 Metro Maryland Ostomy Association, In c., a Rockville, MD based non-profit organization housed in the Non-Profit Village of Montgomery County is pleased to announce the launch of its 40th Anniversary celebration in concert with its new Flagship Project "IT GUTS BETTER"....

2013-12-09 20:23:04

Takeda announces positive vote on vedolizumab to treat ulcerative colitis and Crohn's disease DEERFIELD, Ill. and OSAKA, Japan, Dec. 9, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that a joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees of the United States (U.S.) Food and Drug Administration (FDA) voted to...

2013-12-06 11:25:58

Findings could reshape research on cancer origins and treatment of other autoimmune diseases Johns Hopkins scientists have found evidence that cancer triggers the autoimmune disease scleroderma, which causes thickening and hardening of the skin and widespread organ damage. A report on the discovery, published in the Dec. 5 issue of Science, also suggests that a normal immune system is critical for preventing the development of common types of cancer. According to researchers,...